Janet Veatch

Phase II Study on the Effect of Disease Sites, Age, and Prior Therapy on Response to Iodine-131-Metaiodobenzylguanidine Therapy in Refractory Neuroblastoma

Katherine K. Matthay, Gregory A. Yanik, Julia A. Messina et al. · Journal of Clinical Oncology · 2007 · 265 citations

Medicine, Nuclear Medicine, Oncology +12

Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study

Katherine K. Matthay, Jessica Tan, Judith G. Villablanca et al. · Journal of Clinical Oncology · 2006 · 195 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.

Katherine K. Matthay, C Panina, John P. Huberty et al. · PubMed · 2001 · 161 citations

Medicine, Nuclear Medicine, Oncology +16

Malignant Pheochromocytomas and Paragangliomas

Paul A. FitzGerald, Robert E. Goldsby, John P. Huberty et al. · Annals of the New York Academy of Sciences · 2006 · 131 citations

Medicine, Nuclear Medicine, Oncology +8

Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

Katherine K. Matthay, Alekist Quach, John P. Huberty et al. · Journal of Clinical Oncology · 2009 · 119 citations · Full text

Medicine, Nuclear Medicine, Oncology +16